NCT05643768Completed
Inspiratory Muscle Strength Training in Adults With Type 2 Diabetes
Effects of Inspiratory Muscle Strength Training on Metabolic and Cardiovascular Health in Adults With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 14 Jun 2024
Brief summary (registry, in English)
This clinical research study will investigate the effects of 6 weeks of inspiratory muscle strength training on metabolic and cardiovascular outcomes in adults with recent-onset type 2 diabetes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 11 (actual)
- First submitted
- 30 Nov 2022
- Start date
- 30 Jun 2023
- Primary completion date
- 6 May 2024
- Lead sponsor
- University of Arizona
- Diseases
- High blood pressure, Type 2 diabetes
- NCT number
- NCT05643768
What you commit to
- Study type: Interventional
- Participants enrolled: 11
- From 30 Jun 2023 to the primary completion date, 6 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- myocardial infarction or stroke within the previous 12 months
- medications that, in the opinion of the study physician or nurse practitioner, may impact the outcomes of the study (e.g., steroids)
Other illness
- have an uncontrolled medical condition (e.g., cancer)
- history of perforated eardrum
- history of glaucoma or retinopathy
- history of collapsed lung
Other
- current smoker (including tobacco products, vaping devices, THC, etc…)
- performs regular aerobic exercise (\>4 bouts/week)
- BMI ≥ 40 kg/m2
- systolic blood pressure \<120 or ≥170 mmHg
- diastolic blood pressure \>100 or \<60 mmHg
- Cheyne-Stokes respiration
- diagnosed with asthma
- pregnant, breastfeeding, or trying to become pregnant (self-reported)
Who the study is looking for
- diagnosed with type 2 diabetes by physician
- fasting plasma glucose levels ≥126 mg/dl and ≤240 mg/dl
- systolic blood pressure between 120-169 mmHg
- stable dose of medication (three months on the same dose)
- weight stable in the prior 3 months (\<3.0 kg weight change) and willing to remain weight stable throughout the study
- absence of unstable clinical disease as determined by medical history
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Arizona Respiratory and Neurophysiology Laboratory Coordinator of this site? Confirm its status | Tucson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.